PHAT - Phathom Pharmaceuticals, Inc.
IEX Last Trade
6.62
0.200 3.021%
Share volume: 1,191,003
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.28%
PREVIOUS CLOSE
CHG
CHG%
$6.42
-0.32
-0.05%
Summary score
10%
Profitability
0%
Dept financing
25%
Liquidity
75%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-19.89%
Return on sales
-4779.08%
Return on invested capital
0%
Total debt ratio
120.73%
Debt ratio change over timeo
-0.97%
Current Ratio
9.24%
Quick Ratio
8.54%
Cash Position Ratio
8.83%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-16.38%
Return on sales
-4779.08%
Return on invested capital
0%
Total debt ratio
121.69%
Debt ratio change over timeo
-0.97%
Current Ratio
9.04%
Quick Ratio
9.02%
Cash Position Ratio
8.57%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-19.63%
Return on sales
-3658.68%
Return on invested capital
0%
Total debt ratio
141.66%
Debt ratio change over time
-0.97%
Current Ratio
7.83%
Quick Ratio
7.8%
Cash Position Ratio
7.41%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-100.44%
Return on sales
-205.86%
Return on invested capital
0%
Total debt ratio
-97.33%
Debt ratio change over time
-0.97%
Current Ratio
-0.8%
Quick Ratio
-0.81%
Cash Position Ratio
-0.8%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PHAT | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0% | 18.83% | 17.34% | 7.6% |
| Return on assets | -19.89% | 4.04% | 8.21% | 3.14% |
| Return on sales | -4779.08% | 27.34% | 41.18% | 25.2% |
| Return on invested capital | 0% | 9.79% | -219.55% | 7.46% |
| Profitability | 0% | 79% | 73% | 54% |
| Total debt ratio | 120.73% | 82.79% | 55.88% | 60.06% |
| Debt ratio change over time | -0.97% | -3.75% | -0.73% | -31.28% |
| Dept financing | 25% | 17% | 37% | 12% |
| Current Ratio | 9.04% | 1.15% | 0% | 1.14% |
| Quick Ratio | 9.02% | 0.89% | 0% | 0.89% |
| Cash Position Ratio | 8.57% | 0.13% | 0% | 0.5% |
| Liquididy | 75% | 7% | 6% | 8% |
| Short-term ratios | PHAT | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0% | 13.31% | 0% | 13.48% |
| Return on assets | -16.38% | 4.2% | 0% | 2.81% |
| Return on sales | -4779.08% | 27.79% | 0% | 24.93% |
| Return on invested capital | 0% | 10.68% | 0% | 13.96% |
| Profitability | 0% | 94% | 0% | 89% |
| Total debt ratio | 121.69% | 80.95% | 0% | 59.36% |
| Debt ratio change over time | -0.97% | -32.19% | 0% | 7.3% |
| Dept financing | 25% | 17% | 0% | 37% |
| Current Ratio | 9.04% | 1.15% | 0% | 1.14% |
| Quick Ratio | 9.02% | 0.89% | 0% | 0.89% |
| Cash Position Ratio | 8.57% | 0.13% | 0% | 0.5% |
| Liquididy | 75% | 6% | 0% | 7% |